Randomized clinical trial comparing standard diet with perioperative oral immunonutrition in total gastrectomy for gastric cancer

被引:76
|
作者
Ida, S. [1 ]
Hiki, N. [1 ]
Cho, H. [2 ]
Sakamaki, K. [3 ]
Ito, S. [4 ]
Fujitani, K. [5 ]
Takiguchi, N. [7 ]
Kawashima, Y. [8 ]
Nishikawa, K. [6 ]
Sasako, M. [9 ]
Aoyama, T. [2 ]
Honda, M. [1 ]
Sato, T. [2 ]
Nunobe, S. [1 ]
Yoshikawa, T. [2 ]
机构
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Tokyo, Japan
[2] Yokohama City Univ, Med Ctr, Dept Gastrointestinal Surg, Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
[3] Yokohama City Univ, Med Ctr, Dept Biostat & Epidemiol, Yokohama, Kanagawa, Japan
[4] Aichi Canc Ctr, Dept Surg Gastroenterol, Nagoya, Aichi, Japan
[5] Osaka Gen Med Ctr, Osaka, Japan
[6] Osaka Med Ctr, Osaka, Japan
[7] Chiba Canc Ctr, Div Gastroenterol Surg, Chiba, Japan
[8] Saitama Canc Ctr, Div Gastroenterol Surg, Saitama, Japan
[9] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo, Japan
关键词
S-1 ADJUVANT CHEMOTHERAPY; INDEPENDENT RISK-FACTOR; BODY-WEIGHT LOSS; EICOSAPENTAENOIC ACID; SURGERY; SUPPLEMENTATION; RECONSTRUCTION; CONTINUATION; MASS;
D O I
10.1002/bjs.10417
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Total gastrectomy for gastric cancer is associated with excessive weight loss and decreased calorie intake. Nutritional support using eicosapentaenoic acid modulates immune function and limits catabolism in patients with advanced cancer, but its impact in the perioperative period is unclear. Methods: Thiswas a randomized phase III clinical trial of addition of eicosapentaenoic acid-rich nutrition to a standard diet in patients having total gastrectomy for gastric cancer. Patients were randomized to either a standard diet or standard diet with oral supplementation of an eicosapentaenoic acid (ProSure (R)), comprising 600 kcal with 2.2 g eicosapentaenoic acid, for 7 days before and 21 days after surgery. The primary endpoint was percentage bodyweight loss at 1 and 3 months after surgery. Results: Of 127 eligible patients, 126 were randomized; 124 patients (61 standard diet, 63 supplemented diet) were analysed for safety and 123 (60 standard diet, 63 supplemented diet) for efficacy. Across both groups, all but three patients underwent total gastrectomy with Roux-en-Y reconstruction. Background factors were well balanced between the groups. Median compliance with the supplement in the immunonutrition group was 100 per cent before and 54 per cent after surgery. The surgical morbidity rate was 13 per cent in patients who received a standard diet and 14 per cent among those with a supplemented diet. Median bodyweight loss at 1 month after gastrectomy was 8.7 per cent without dietary supplementation and 8.5 per cent with eicosapentaenoic acid enrichment (P = 0.818, adjusted P = 1.000). Similarly, there was no difference between groups in percentage bodyweight loss at 3 months (P = 0.529, adjusted P = 1.000). Conclusion: Immunonutrition based on an eicosapentaenoic acid-enriched oral diet did not reduce bodyweight loss after total gastrectomy for gastric cancer compared with a standard diet. Registration number: UMIN000006380 (http://www.umin.ac.jp/)
引用
收藏
页码:377 / 383
页数:7
相关论文
共 50 条
  • [1] Prospective randomized trial of preoperative enteral immunonutrition followed by elective total gastrectomy for gastric cancer
    Fujitani, K.
    Tsujinaka, T.
    Fujita, J.
    Miyashiro, I.
    Imamura, H.
    Kimura, Y.
    Kobayashi, K.
    Kurokawa, Y.
    Shimokawa, T.
    Furukawa, H.
    BRITISH JOURNAL OF SURGERY, 2012, 99 (05) : 621 - 629
  • [2] Clinical and Immunological Impact of Early Postoperative Enteral Immunonutrition After Total Gastrectomy in Gastric Cancer Patients: A Prospective Randomized Study
    Marano, Luigi
    Porfidia, Raffaele
    Pezzella, Modestino
    Grassia, Michele
    Petrillo, Marianna
    Esposito, Giuseppe
    Braccio, Bartolomeo
    Gallo, PierLuigi
    Boccardi, Virginia
    Cosenza, Angelo
    Izzo, Giuseppe
    Di Martino, Natale
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (12) : 3912 - 3918
  • [3] Clinical and Immunological Impact of Early Postoperative Enteral Immunonutrition After Total Gastrectomy in Gastric Cancer Patients: A Prospective Randomized Study
    Luigi Marano
    Raffaele Porfidia
    Modestino Pezzella
    Michele Grassia
    Marianna Petrillo
    Giuseppe Esposito
    Bartolomeo Braccio
    PierLuigi Gallo
    Virginia Boccardi
    Angelo Cosenza
    Giuseppe Izzo
    Natale Di Martino
    Annals of Surgical Oncology, 2013, 20 : 3912 - 3918
  • [4] Randomized clinical trial comparing early enteral immunonutrition and standart nutrition in patients with gastric cancer undergoing radical resection
    Yagci, G.
    Can, M. F.
    Ozerhan, I. H.
    Ozturk, E.
    Safak, H.
    Dag, B.
    Ozgurtas, T.
    Aydin, I.
    Cetiner, S.
    BRITISH JOURNAL OF SURGERY, 2010, 97 : S53 - S53
  • [5] Multicentre factorial randomized clinical trial of perioperative immunonutrition versus standard nutrition for patients undergoing surgical resection of oesophageal cancer
    Mudge, L. A.
    Watson, D. I.
    Smithers, B. M.
    Isenring, E. A.
    Smith, L.
    Jamieson, G. G.
    BRITISH JOURNAL OF SURGERY, 2018, 105 (10) : 1262 - 1272
  • [6] A prospective randomized clinical trial comparing D2 dissection in laparoscopic and open gastrectomy for gastric cancer
    Cui, Ming
    Li, Ziyu
    Xing, Jiadi
    Yao, Zhendan
    Liu, Maoxing
    Chen, Lei
    Zhang, Chenghai
    Yang, Hong
    Zhang, Nan
    Tan, Fei
    Jiang, Beihai
    Di, Jiabo
    Wang, Zaozao
    Ji, Jiafu
    Su, Xiangqian
    MEDICAL ONCOLOGY, 2015, 32 (10)
  • [7] A prospective randomized clinical trial comparing D2 dissection in laparoscopic and open gastrectomy for gastric cancer
    Ming Cui
    Ziyu Li
    Jiadi Xing
    Zhendan Yao
    Maoxing Liu
    Lei Chen
    Chenghai Zhang
    Hong Yang
    Nan Zhang
    Fei Tan
    Beihai Jiang
    Jiabo Di
    Zaozao Wang
    Jiafu Ji
    Xiangqian Su
    Medical Oncology, 2015, 32
  • [8] A phase III trial to confirm preventing effects of perioperative enteral EPA-enriched immunonutrition on body weight loss after total gastrectomy for gastric cancer
    Hiki, N.
    Yoshikawa, T.
    Sakamaki, K.
    Ito, S.
    Fujitani, K.
    Takiguchi, N.
    Kawashima, Y.
    Nishikawa, K.
    Sasako, M.
    Ida, S.
    Aoyama, T.
    Honda, M.
    Sato, T.
    Nunobe, S.
    Cho, H.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S171 - S171
  • [9] Comparing postoperative morbidity and mortality in a randomized clinical trial of total versus subtotal gastrectomy
    Bozzetti, F
    Bonfanti, G
    Palmieri, S
    Rubino, A
    Gennari, L
    GI CANCER, 1995, 1 (02): : 135 - 140
  • [10] A PROSPECTIVE RANDOMIZED TRIAL COMPARING R(1) SUBTOTAL GASTRECTOMY WITH R(3) TOTAL GASTRECTOMY FOR ANTRAL CANCER
    ROBERTSON, CS
    CHUNG, SCS
    WOODS, SDS
    GRIFFIN, SM
    RAIMES, SA
    LAU, JTF
    LI, AKC
    ANNALS OF SURGERY, 1994, 220 (02) : 176 - 182